Glycosphingolipid Dysregulation in Congenital Disorders of Glycysolation (CDG)

Karlstad University

Leuven

Vor Ort

EUR 24.000 - 30.000

Vollzeit

14 Tage+

Erhalte eine Antwort von diesem Arbeitgeber

Dein Lebenslauf und dein Anschreiben, genau auf das zugeschnitten, was gesucht wird.

Schaffe es an den ATS-Filtern vorbei

Zusammenfassung

KU Leuven invites applications for a fully funded PhD position in Glycosphingolipid Dysregulation in Congenital Disorders of Glycosylation (CDG). The project sits at the crossroads of rare disease research, neuroscience, systems biology, metabolomics and lipidomics.

You will work with patient-derived fibroblasts, perform advanced lipidomics, integrate multi-omics data, and publish in high‑quality journals.

Qualifikationen

  • Master's degree in Biomedical Sciences, Biology, Medicine, Bioengineering, Biochemistry, Biotechnology, Pharmaceutical Sciences, Bioinformatics or a related discipline.
  • Excellent academic results are expected.
  • Strong interest in rare diseases, metabolism, neuroscience or molecular medicine.

Aufgaben

  • Conduct innovative research leading to a PhD degree.
  • Perform experiments involving cell culture, lipidomics, metabolomics and molecular biology.
  • Analyse and integrate complex multi-omics datasets.
  • Present research findings at national and international meetings.
  • Publish research in high-quality scientific journals.
  • Participate in national and international collaborations.
  • Support supervision of Master’s thesis students.

Kenntnisse

Strong communication
Scientific writing
Independent work
Collaborative teamwork
Programming
Omics technologies
Mass spectrometry
Cell culture

Ausbildung

Master's degree in Biomedical Sciences or related field

Tools

Mass spectrometry
Cell culture

Jobbeschreibung

Glycosphingolipid Dysregulation in Congenital Disorders of Glycysolation (CDG)

KU Leuven is an autonomous university. It was founded in 1425. It was born of and has grown within the Catholic tradition.

The project is embedded within the department of development and regeneration KU Leuven and the Laboratory of Applies Mass Spectrometry – Metabolomics expertise center. The candidate will collaborate closely with experts in clinical genetics, metabolomics, lipidomics, glycobiology and systems biology.

The research environment provides:

  • Access to unique international collections of CDG patient samples
  • State‑of‑the‑art mass spectrometry infrastructure
  • Advanced multi‑omics platforms
  • Extensive international collaborations
  • Opportunities for conference participation and international training
Project

Congenital disorders of glycosylation (CDG) comprise more than 200 individually rare inherited metabolic disorders and represent one of the most rapidly expanding groups of inborn errors of metabolism. While abnormalities of protein glycosylation have traditionally been considered the primary disease mechanism, many CDG patients present with severe neurological manifestations that remain only partially understood.

Recent work from our research group has identified glycosphingolipids (GSLs), including gangliosides, as a potentially critical but underexplored disease mechanism in CDG. Because glycosphingolipids constitute the majority of glycan structures in the central nervous system and are essential for neuronal development, signalling and synaptic function, understanding their dysregulation may open entirely new therapeutic avenues.

This PhD project forms part of a larger translational research programme aimed at developing mechanism‑based treatments for CDG. The successful candidate will work at the intersection of rare disease research, neuroscience, systems biology, metabolomics and lipidomics.

Research Objectives

Objective 1 – Defining glycosphingolipid abnormalities in CDG

The candidate will perform comprehensive glycosphingolipid and ganglioside profiling in an extensive collection of patient‑derived fibroblasts representing multiple CDG subtypes. Using state‑of‑the‑art lipidomics and tracer‑based metabolomics, metabolic bottlenecks and pathway rerouting events will be identified. Treatment options will be explored.

Objective 2 – Investigating disease mechanisms and therapeutic opportunities

Key findings will be validated in neuronal‑relevant cellular models generated through CRISPR‑mediated genetic engineering and pharmacological perturbation approaches. Multi‑omics integration (lipidomics, metabolomics, proteomics and transcriptomics) will be used to identify pathogenic mechanisms and nominate therapeutic interventions, including glycosphingolipid supplementation and drug repurposing strategies.

The project builds upon unique patient cohorts, extensive preliminary data, and internationally recognised expertise in congenital disorders of glycosylation.

Profile
  • Holds (or will soon obtain) a Master’s degree in Biomedical Sciences, Biology, Medicine, Bioengineering, Biochemistry, Biotechnology, Pharmaceutical Sciences, Bioinformatics or a related discipline
  • Has obtained excellent academic results
  • Demonstrates a strong interest in rare diseases, metabolism, neuroscience or molecular medicine
  • Has an interest in advanced laboratory techniques and data analysis
  • Possesses strong communication and scientific writing skills
  • Is able to work independently while thriving in a collaborative multidisciplinary team
  • Experience with cell culture, molecular biology, mass spectrometry, bioinformatics, programming or omics technologies is considered an asset but is not mandatory
Responsibilities
  • Conduct innovative research leading to a PhD degree
  • Perform experiments involving cell culture, lipidomics, metabolomics and molecular biology
  • Analyse and integrate complex multi‑omics datasets
  • Present research findings at national and international meetings
  • Publish research in high‑quality scientific journals
  • Participate in national and international collaborations
  • Support supervision of Master’s thesis students
Offer

KU Leuven offers a stimulating international research environment with excellent training opportunities. The successful candidate will join a dynamic team of clinicians, PhD students, postdoctoral researchers and technicians working on rare metabolic diseases and translational therapeutic development.

Successful completion of the programme will lead to the degree of Doctor of Biomedical Sciences.

Funding and Appointment
  • Fully funded PhD position (4‑year trajectory subject to successful evaluation according to KU Leuven regulations)
  • Competitive salary according to KU Leuven doctoral scholarship scales
  • Expected start date: flexible, preferably October 2026
Equal Opportunity

KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.

Hol dir deinen kostenlosen, vertraulichen Lebenslauf-Check.

oder ziehe deine Datei hierhin.

Similar jobs

Ähnliche Jobs, die dir auch gefallen könnten

PhD on ERC StG DOLIGOAL – Understanding the regulation of dolichol synthesis and interactions with cholesterol metabolism
PhD on ERC StG DOLIGOAL – Understanding the regulation of dolichol synthesis and interactions with cholesterol metabolism

KU LEUVEN • Vlaams-Brabant

Vor Ort
EUR 45.000 - 55.000
Postdoctoral researcher on ERC StG DOLIGOAL – Uncover missing elements in the metabolism of the overlooked lipid dolichol
Postdoctoral researcher on ERC StG DOLIGOAL – Uncover missing elements in the metabolism of the overlooked lipid dolichol

KU LEUVEN • Vlaams-Brabant

Vor Ort
EUR 52.000 - 76.000
Full-time contract
1-year contract with possible renewal
Travel opportunities
+3
PhD: Glycosphingolipid Dysregulation in CDG & Neuro Metabolism
PhD: Glycosphingolipid Dysregulation in CDG & Neuro Metabolism

Karlstad University • Leuven

Vor Ort
EUR 24.000 - 30.000
Doctoral Candidate Position in Spatial Multi-Omics
Doctoral Candidate Position in Spatial Multi-Omics

KU Leuven • Belgien

Vor Ort
EUR 32.000 - 38.000
36-month scholarship
Secondments to AtlasXomics
Secondments to Intelligent Biodata
Postdoctoral position in the lab of Computational Neurobiology
Postdoctoral position in the lab of Computational Neurobiology

University of Antwerp • Belgien

Vor Ort
EUR 42.000 - 54.000
Two-year funding with extension
Fellowship applications support (FWO,?
Access to state-of-the-art facilities
+3
Postdoc in Dolichol Metabolism & CDG Discovery (ERC Start)
Postdoc in Dolichol Metabolism & CDG Discovery (ERC Start)

KU Leuven • Vlaams-Brabant

Vor Ort
EUR 52.000 - 76.000
Full-time contract
1-year contract with possible renewal
Travel opportunities
+3
Postdoctoral Researcher in Cancer Cell Plasticity and Functional Genomics
Postdoctoral Researcher in Cancer Cell Plasticity and Functional Genomics

VIB • Vlaams-Brabant

Vor Ort
EUR 42.000 - 52.000
Funding for 3 years
Scientific freedom and mentorship
Conference opportunities
+1
Postdoctoral Position in the Computational Neurobiology Lab
Postdoctoral Position in the Computational Neurobiology Lab

VIB BV • Antwerpen

Hybrid
EUR 42.000 - 54.000
Two-year contract with VIB/UAntwerp
Independent funding support
Training programs
+2
Postdoctoral Position in the Computational Neurobiology Lab
Postdoctoral Position in the Computational Neurobiology Lab

VIB • Antwerpen

Vor Ort
EUR 42.000 - 66.000
Two-year contract with possible extend
Opportunity to apply for personal/fell
Access to state-of-the-art core labs
+2
MSCA PhD Vacancy at KU Leuven for INTELLASE (DC14) “Development of multi-sensor fusion methodologies for femtosecond laser machining”
MSCA PhD Vacancy at KU Leuven for INTELLASE (DC14) “Development of multi-sensor fusion methodologies for femtosecond laser machining”

KU Leuven • Vlaams-Brabant

Vor Ort
EUR 55.000 - 65.000